Literature DB >> 22412056

Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City.

Holly A Anger1, Douglas Proops, Tiffany G Harris, Jiehui Li, Barry N Kreiswirth, Elena Shashkina, Shama D Ahuja.   

Abstract

BACKGROUND: Tuberculosis contact investigation identifies individuals who may be recently infected with tuberculosis and are thus at increased risk for disease. Contacts with latent tuberculosis infection (LTBI) are offered chemoprophylaxis to prevent active disease; however, the effectiveness of this intervention is unclear as treatment completion is generally low.
METHODS: A retrospective cohort study of 30 561 contacts identified during investigation of 5182 cases of tuberculosis diagnosed in New York City, 1997-2003, was performed. We searched the NYC tuberculosis registry to identify contacts developing active tuberculosis within 4 years of follow-up. We estimated the following: number of contacts undergoing evaluation (ie, tuberculin skin test and/or chest radiograph) per prevalent case diagnosed; number of contacts with LTBI that need to be treated with standard chemoprophylaxis to prevent 1 active case.
RESULTS: Of 30 561 contacts, 27 293 (89%) were evaluated and 268 prevalent cases were diagnosed (102 contacts evaluated per prevalent case diagnosed, 95% confidence interval [CI], 90-115). LTBI was diagnosed in 7597 contacts, including 6001 (79%) who initiated chemoprophylaxis, 3642 (61%) who later completed treatment, and 2359 (39%) who did not complete treatment. During 4 years of follow-up, active tuberculosis was diagnosed in 46 contacts with LTBI, including 22 of 6001 (0.4%) who initiated chemoprophylaxis and 24 of 1596 (1.5%) who did not initiate treatment. The absolute risk reduction afforded by chemoprophylaxis initiation was 1.1% (95% CI, .6%-1.9%), leading to an estimated 88 contacts treated to prevent 1 tuberculosis case (95% CI, 53-164).
CONCLUSIONS: Contact investigation facilitates active case finding and tuberculosis prevention, even when completion rates of chemoprophylaxis are suboptimal.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22412056     DOI: 10.1093/cid/cis029

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Risk Factors for Tuberculosis and Effect of Preventive Therapy Among Close Contacts of Persons With Infectious Tuberculosis.

Authors:  Mary R Reichler; Awal Khan; Timothy R Sterling; Hui Zhao; Bin Chen; Yan Yuan; Joyce Moran; James McAuley; Bonita Mangura
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

2.  Risk for Tuberculosis Disease Among Contacts with Prior Positive Tuberculin Skin Test: A retrospective Cohort Study, New York City.

Authors:  Prabhu P Gounder; Tiffany G Harris; Holly Anger; Lisa Trieu; Jeanne Sullivan Meissner; Betsy L Cadwell; Elena Shashkina; Shama D Ahuja
Journal:  J Gen Intern Med       Date:  2015-01-21       Impact factor: 5.128

3.  Improved treatment completion with shorter treatment regimens for latent tuberculous infection.

Authors:  M M Macaraig; M Jalees; C Lam; J Burzynski
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

4.  Control measures to trace ≤ 15-year-old contacts of index cases of active pulmonary tuberculosis.

Authors:  Cláudia Di Lorenzo Oliveira; Angelita Cristine de Melo; Lílian Ruth Silva de Oliveira; Emerson Lopes Froede; Paulo Camargos
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

5.  Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.

Authors:  Mary R Reichler; Awal Khan; Timothy R Sterling; Hui Zhao; Joyce Moran; James McAuley; Patricia Bessler; Bonita Mangura
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

6.  Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.

Authors:  Beate Kampmann; James A Seddon; James Paton; Zohreh Nademi; Denis Keane; Bhanu Williams; Amanda Williams; Sue Liebeschutz; Anna Riddell; Jolanta Bernatoniene; Sanjay Patel; Nuria Martinez; Paddy McMaster; Robindra Basu-Roy; Steven B Welch
Journal:  Am J Respir Crit Care Med       Date:  2018-04-15       Impact factor: 21.405

7.  Using routinely reported tuberculosis genotyping and surveillance data to predict tuberculosis outbreaks.

Authors:  Sandy P Althomsons; J Steven Kammerer; Nong Shang; Thomas R Navin
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  Exploring genotype concordance in epidemiologically linked cases of tuberculosis in New York City.

Authors:  R S Robbins; B R Perri; S D Ahuja; H A Anger; J Sullivan Meissner; E Shashkina; B N Kreiswirth; D C Proops
Journal:  Epidemiol Infect       Date:  2016-11-21       Impact factor: 4.434

Review 9.  Interventions to increase tuberculosis case detection at primary healthcare or community-level services.

Authors:  Francis A Mhimbira; Luis E Cuevas; Russell Dacombe; Abdallah Mkopi; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2017-11-28

10.  Contemporary Social Disparities in TB Infection and Disease in the USA: a Review.

Authors:  Grace A Noppert; Ryan E Malosh; Elizabeth B Moran; Shama D Ahuja; Jon Zelner
Journal:  Curr Epidemiol Rep       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.